Viruses: An important cause of human cancer;Los virus: Una importante causa de neoplasias en los seres humanos

Revista de Investigacion Clinica

Volumn 56, Issue 4, 2004, Pages 495-506

  Delgado Enciso, Iván ^a   Rojas Martínez, Augusto ^a   Barrera Saldaña, Hugo A ^a   Ortiz López, Rocío ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Epidemiology; Neoplasms; Oncogenes; Oncogenic viruses; Risk factors

Indexed keywords

FLICE INHIBITORY PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; LATENT MEMBRANE PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN E6; PROTEIN E7; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; TAX PROTEIN; TRANSCRIPTION FACTOR E2F; VIRUS DNA; VIRUS PROTEIN;

ADENOVIRUS; APOPTOSIS; BK VIRUS; CANCER INCIDENCE; CANCER INHIBITION; CANCER RISK; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; JC VIRUS; LIVER CANCER; NONHODGKIN LYMPHOMA; ONCOGENE C FOS; ONCOGENE C MYC; ONCOVIRINAE; PROPHYLAXIS; REVIEW; RISK FACTOR; SIMIAN VIRUS 40; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS ONCOGENE; WART VIRUS;

FORECASTING; HEPATITIS VIRUSES; HERPESVIRUS 4, HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; NEOPLASMS; ONCOGENIC VIRUSES; PAPILLOMAVIRIDAE;

EID: 7444229324     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Rous P. A transmissible avian neoplasm. (Sarcoma of the common fowl) by Peyton Rous, M.D., Experimental Medicine for Sept. 1, 1910, vol. 12, pp.696-705. J Exp Med 1979; 150: 738-3.
2. Epstein MA. Reflections on Epstein-Barr virus: some recently resolved old uncertainties. J Infect 2001; 43: 111-15.
3. zur Hansen H. Viruses in human cancers. Eur J Cancer 1999; 35: 1878-85.
4. Lewin B. Oncogenes and cancer. In: Genes VII. Oxford: Oxford University Press; 2000, p. 875-912.
5. zur Hausen H. Viruses in human cancers. Science 1991; 254: 1167-73.
6. Niederman JC. Infectious mononucleosis: observations on transmission. Yale J Biol Med 1982; 55: 259-64.
7. Haque T, Thomas JA, Falk KI, Parratt R, Hunt BJ, Yacoub M, Crawford DH. Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients. J Gen Virol 1996; 77: 1169-72.
8. Maddrey WC. Hepatitis B-an important public health issue. Clin Lab 2001; 47: 51-5.
9. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 2000; 18(Suppl. 1): S17-S19.
10. Ladron-de Guevara L, Gomez N, Vazquez-Cantarell M, Garcia-Mendez S, Di Silvio M. Prevalencia y factores de riesgo para hepatitis C en donadores de sangre. Rev Gastroenterol Mex 2002; 67: 11-16.
11. Alvarez-Munoz MT, Vences-Aviles MA, Damacio L, Vazquez-Rosales G, Torres J, Gonzalez-Bravo F, Munoz O. Hepatitis C virus RNA (HCV-RNA) in blood donors and family members seropositive for anti-HCV antibodies. Arch Med Res 2001; 32: 442-5.
12. Ayala Gaytan JJ, Guerra Avalos FJ, Mora Brondo P, Casillas Romo A. Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico. Rev Gastroenterol Mex 1997; 62: 250-3.
13. Pita-Ramirez L, Torres-Ortiz GE. Prevalence of viral antibodies and syphilis serology in blood donors from a hospital. Rev Invest Clin 1997; 49: 475-80.
14. Mendez-Sanchez N, Baptista-Gonzalez H, Sanchez-Gomez RH, Bordes-Aznar J, Uribe-Esquivel M. The prevalence of hepatitis B and C in blood donors in a 3rd-level hospital of Mexico City Sal Pub Mex 2000; 42: 174-7.
15. Ceci O, Margiotta M, Marello F, Francavilla R, Loizzi P, Francavilla A, Mautone A, Impedovo L, Ierardi E, Mastroianni M, Bettocchi S, Selvaggi L. Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr 2001; 33: 570-5.
16. Frega A, Cenci M, Stentella P, Cipriano L, De Ioris A, Alderisio M, Vecchione A. Human papillomavirus in virgins and behaviour at risk. Cancer Lett 2003; 194: 21-4.
17. Poiesz BJ, Papsidero LD, Ehrlich G, Sherman M, Dube S, Poiesz M, Dillon K, Ruscetti FW, Slamon D, Fang C, Williams A, Duggan D, Glaser J, Gottlieb A, Goldberg J, Ratner L, Phillips P, Han T, Friedman-Kien A, Siegal F, Rai K, Sawitsky A, Sheremata LW, Dosik H, Cunningham C, Montagna R. Prevalence of HTLV-I-associated T-cell lymphoma. Am J Hematol 2001; 66: 32-8.
18. Flores-Castañeda MS, Salinas-Carmona MC, Leal-Gonzalez C, Yanez-Rodriguez A, Trejo-Avila LM. Antibodies against human T-cell lymphotropic viruses in subjects at high risk for HIV in Monterrey. Rev Invest Clin 1992; 44: 37-41.
19. Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 2000; 18: 109-19.
20. Chatlynne LG, Ablashi DV. Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol 1999; 9: 175-85.
21. Sosa C, Benetucci J, Hanna C, Sieczkowski L, Deluchi G, Canizal AM, Mantina H, Klaskala W, Baum M, Wood C. Human herpesvirus 8 can be transmitted through blood in drug addicts. Medicina 2001; 61: 291-4.
22. Atkinson J, Edlin BR, Engels EA, Kral AH, Seal K, Gamache CJ, Whitby D, O'Brien TR. Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis 2003; 187: 974-81.
23. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000; 343: 1369-77.
24. Klussmann JP, Muller A, Wagner M, Guntinas-Lichius O, Jungehuelsing M, Sloots T, Ablashi DV, Krueger GR. Human herpesvirus type 8 in salivary gland tumors. J Clin Virol 2000; 16: 239-46.
25. Tosato G, Taga K, Angiolillo AL, Sgadari C. Epstein-Barr virus as an agent of haematological disease. Baillieres Clin Haematol 1995; 8: 165-99.
26. Blaho JA, Aaronson SA. Convicting a human tumor virus: Guilt by association? Proc Natl Acad Sci USA 1999; 96: 7484-9.
27. Goldenberg D, Golz A, Netzer A, Rosenblatt E, Rachmiel A, Goldenberg RF, Joachims HZ. Epstein-Barr virus and cancers of the head and neck. Am J Otolaryngol 2001; 22: 197-205.
28. Niedobitek G, Meru N, Delecluse HJ. Epstein-Barr virus infection and human malignancies. Int J Exp Pathol 2001; 82: 149-70.
29. Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V, Raab-Traub N. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci USA 1998; 95: 11963-8.
30. Kitchingman GR, Rooney C. Cytotoxic T cells and immunotherapy. Pediatr Radiol 1998; 28: 489-91.
31. Maeda M. Human T lymphotropic virus type-I (HTLV-I) immortalizes human T cells in vitro-its implication in the pathogenesis of adult T cell leukemia (ATL). Hum Cell 1992; 5: 70-8.
32. Arisawa K, Soda M, Endo S, Kurokawa K, Katamine S, Shimokawa I, Koba T, Takahashi T, Saito H, Doi H, Shirahama S. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 2000; 85: 319-24.
33. Georges SA, Giebler HA, Cole PA, Luger K, Laybourn PJ, Nyborg JK. Tax recruitment of CBP/p300, via the KIX domain, reveals a potent requirement for acetyltransferase activity that is chromatin dependent and histone tail independent. Mol Cell Biol 2003; 23: 3392-404.
34. Terashima A, Alvarez H, Tello R, Infante R, Freedman DO, Gotuzzo E. Treatment failure in intestinal Strongyloidiasis: an indicator of HTLV-1 infection. Int J Infect Dis 2002; 6: 28-30.
35. Gotuzzo E, Arango C, de Queiroz-Campos A, Isturiz RE. Human T-cell lymphotropic virus-I in Latin America. Infect Dis Clin North Am 2000; 14: 211-39.
36. Wong's virology. HTLV-1. http://virology-online.com/viruses/HTLV.htm
37. Maddrey WC. Hepatitis B-an important public health issue. Clin Lab 2001; 47: 51-5.
38. Division of viral hepatitis. Centers for disease control and prevention. National Center for Infectious Diseases. http://www.cdc.gov/ncidod/diseases/hepatitis/b/fact.htm.
39. Molmenti EP, Klintmalm GB. Hepatocellular cancer in liver transplantation. J Hepatobiliary Pancreat Surg 2001; 8: 427-34.
40. Kato N. Molecular virology of hepatitis C virus. Acta Med Okayama 2001; 55: 133-59.
41. Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 2001; 28: 441-9.
42. Lechmann M, Liang TJ. Vaccine development for hepatitis C. Semin Liver Dis 2000; 20: 211-26.
43. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-13.
44. Arbuthnot P, Kew M. Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol 2001; 82: 77-100.
45. Gnann JW Jr, Pellett PE, Jaffe HW. Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus. Clin Infect Dis 2000; 30(Suppl. 1): S72-S76.
46. Teruya-Feldstein J, Zauber P, Setsuda JE, Berman EL, Sorbara L, Raffeld M, Tosato G, Jaffe ES. Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma. Lab Invest 1998; 78: 1637-42.
47. Cesarman E, Knowles DM. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Semin Cancer Biol 1999; 9: 165-74.
48. Choi J, Means RE, Damania B, Jung JU. Molecular piracy of Kaposi's sarcoma associated herpesvirus. Cytokine Growth Factor Rev 2001; 12: 245-57.
49. Pfrommer C, Tebbe B, Tidona CA, Wolfer U, Krengel S, Zeichardt H, Zouboulis CC, Orfanos CE. Progressive HHV-8-positive classic Kaposi's sarcoma: rapid response to interferon alpha-2a but persistence of HHV-8 DNA sequences in lesional skin. Br J Dermatol 1998; 139: 516-19.
50. Luppi M, Barozzi P, Rasini V, Riva G, Re A, Rossi G, Setti G, Sandrini S, Facchetti F, Torelli G. Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation 2002; 74: 131-2.
51. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796-802.
52. Sudbo J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 345: 376-7.
53. zur Hansen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991; 184: 9-13.
54. Popescu NC, DiPaolo JA. Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Res 1990; 50: 1316-23.
55. Arends MJ, Buckley CH, Wells M. Aetiology, pathogenesis, and pathology of cervical neoplasia. J Clin Pathol 1998; 51: 96-103.
56. von Knebel Doeberitz M, Rittmuller C, Aengeneyndt F, Jansen-Durr P, Spitkovsky D. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J Virol 1994; 68: 2811-82.
57. Syrjänen K, Syrjänen S. Molecular biology of papillomaviruses. In: Papillomavirus, infections in human pathology. New York: John Wiley & Sons, LTD; 2000, p. 11-51.
58. Stoppler H, Hartmann DP, Sherman L, Schlegel R. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J Biol Chem 1997; 272: 13332-7.
59. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 2120-9.
60. Sanchez-Prieto R, de Alava E, Palomino T, Guinea J, Fernandez V, Cebrian S, Lleonart M, Cabello P, Martin P, San Roman C, Bornstein R, Pardo J, Martinez A, Diaz-Espada F, Barrios Y, Ramon y Cajal S. An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1. Nat Med 1999; 5: 1076-9.
61. Kovar H, Fallaux FJ, Pribill I, Jugovic D, Bartl S, Ambros PF, Aryee DN, Wiegant JC, Hoeben RC. Adenovirus E1A does not induce the Ewing tumor-associated gene fusion EWS-FLI1. Cancer Res 2000; 60: 1557-60.
62. National Immunization Program, CDC, simian virus 40 (SV40), polio vaccine, and cancer. http://www.cdc.gov/nip/vacsafe/concerns/ cancer/sv40-polio-cancer-facts.htm
63. Butel JS, Jafar S, Wong C, Arrington AS, Opekun AR, Finegold MJ, Adam E. Evidence of SV40 infections in hospitalized children. Hum Pathol 1999; 30: 1496-502.
64. Jasani B, Cristaudo A, Emri SA, Gazdar AF, Gibbs A, Krynska B, Miller C, Mutti L, Radu C, Tognon M, Procopio A. Association of SV40 with human tumours. Semin Cancer Biol 2001; 11: 49-61.
65. Elsner C, Dorries K. Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 1992; 191: 72-80.
66. Taguchi F, Kajioka J, Miyamura T. Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol 1982; 26: 1057-64.
67. Reploeg MD, Storch GA, Clifford DB. Bk virus: a clinical review. Clin Infect Dis 2000; 33: 191-202.
68. Del Valle L, Gordon J, Assimakopoulou M, Enam S, Geddes JF, Varakis JN, Katsetos CD, Croul S, Khalili K. Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res 2001; 61: 4287-293.
69. MacKenzie J, Perry J, Ford AM, Jarrett RF, Greaves M. JC and BK virus sequences are not detectable in leukaemic samples from children with common acute lymphoblastic leukaemia. Br J Cancer 1999; 81: 898-9.
70. Krynska B, Del Valle L, Croul S, Gordon J, Katsetos CD, Carbone M, Giordano A, Khalili K. Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci USA 1999; 96: 11519-24.
71. Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV, Boland CR. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci USA 1999; 96: 7484-9.
72. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971-8.
73. Bratt G, Hammarin AL, Grandien M, Hedquist BG, Nennesmo I, Sundelin B, Seregard S. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999; 13: 1071-5.
74. Flaegstad T, Andresen PA, Johnsen JI, Asomani SK, Jorgensen GE, Vignarajan S, Kjuul A, Kogner P, Traavik T. A possible contributory role of BK virus infection in neuroblastoma development. Cancer Res 1999; 59: 1160-3.
75. Rabkin CS, Biggar RJ, Horm JW. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer 1991; 47: 692-6.
76. Spano JP, Atlan D, Breau JL, Farge D. AIDS and non-AIDS-related malignancies: a new vexing challenge in HIV-positive patients. Part I: Kaposi's sarcoma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma. Eur J Intern Med 2002; 13: 170-9.
77. Mohar A, Volkow P, Sanchez-Mejorada G, Sada E, Soto JL, Perez F, Ruiz-Palacios G, Ponce-de Leon S. AIDS and neoplasms in Mexico. Sal Pub Mex 1995; 37: 533-8.
78. Frisch M, Biggar RJ, Engels EA, Goedert JJ; AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285: 1736-45.
79. Remick SC. Non-AIDS-defining cancers. Hematol Oncol Clin North Am 1996; 10: 1203-13.
80. Wistuba II, Behrens C, Gazdar AF. Pathogenesis of non-AIDS-defining cancers: a review. AIDS Patient Care STDS 1999; 13: 415-26.
81. Katariya K, Thurer RJ. Thoracic malignancies associated with AIDS. Semin Thorac Cardiovasc Surg 2000;12:148-153.
82. Smith C, Lilly S, Mann KP, Livingston E, Myers S, Lyerly HK, Miralles GD. AIDS-related malignancies. Ann Med 1998; 30: 323-44.
83. Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer 2001; 37: 1188-201.
84. Nasti G, Vaccher E, Errante D, Tirelli U. Malignant tumors and AIDS. Biomed Pharmacother 1997; 51: 243-51.
85. Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 2002; 16: 441-451, 456, 459.
86. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351: 1833-9.
87. Clarke B, Chetty R. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol 2002; 55: 19-24.
88. Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol 2000; 53: 255-61.
89. Lawson JS, Tran D, Rawlinson WD. From Bittner to Barr: a viral, diet and hormone breast cancer aetiology hypothesis. Breast Cancer Res 2001; 3: 81-5.
90. Gross L. The role of viruses in the etiology of cancer and leukemia in animals and in humans. Proc Natl Acad Sci U S A 1997; 94: 4237-8.
91. zur Hausen H. Proliferation-inducing viruses in non-permissive systems as possible causes of human cancers. Lancet 2001; 357(9253): 381-4.
92. Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 2001; 28: 441-9.
93. Ohashi T, Hanabuchi S, Kato H, Tateno H, Takemura F, Tsukahara T, Koya Y, Hasegawa A, Masuda T, Kannagi M. Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine. J Virol 2000; 74: 9610-16.
94. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. Proof of principle study investigators. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347: 1645-51.
95. Engelbrecht S, Treurnicht FK, Schneider JW, Jordaan HF, Steytler JG, Wranz PA, van Rensburg EJ. Detection of human herpes virus 8 DNA and sequence polymorphism in classical, epidemic, and iatrogenic Kaposi's sarcoma in South Africa. J Med Virol 1997; 52: 168-72.
96. Tsukasaki K, Miller CW, Kubota T, Takeuchi S, Fujimoto T, Ikeda S, Tomonaga M, Koeffler HP. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res 2001; 61: 3770-4.
97. Gioseffi ON, Nucifora E, Fantl D, Dufour C, Milone J, Di Paolo H. Adult HTLV-I positive leukemia-lymphoma in Argentina. Sangre 1995; 40: 421-4.
98. Gotuzzo E, Arango C, de Queiroz-Campos A, Isturiz RE. Human T-cell lymphotropic virus-I in Latin America. Infect Dis Clin North Am 2000; 14: 211-39.